PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
-8.19%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(-17%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
8.88%
Top 10 Holdings %
Top 10 Hldgs %
99.39%
Holding
11
New
–
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
Oculis Holding
OCS
|
$10.7M |
| 2 |
Vaxcyte
PCVX
|
$261K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Oculis Holding
OCS
$844M
| $43.8M | 35.43% | 2,300,774 +563,078 | +32% | +$10.7M |
|
2
Arcutis Biotherapeutics
ARQT
$1.86B
| $33.2M | 26.84% | 2,120,508 | – | – |
|
|
3
Vaxcyte
PCVX
$4B
| $26.8M | 21.72% | 710,734 +6,900 | +1% | +$261K |
|
|
ZBIO
4
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $5.82M | 4.71% | 736,645 | – | – |
|
|
INZY
5
DELISTED
Inozyme Pharma
INZY
| $4.09M | 3.31% | 4,494,851 | – | – |
|
6
Recursion Pharmaceuticals
RXRX
$2.04B
| $3.15M | 2.55% | 595,518 | – | – |
|
|
BIOA
7
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $2.46M | 1.99% | 653,374 | – | – |
|
8
Rallybio
RLYB
$22.4M
| $1.56M | 1.27% | 2,404,644 | – | – |
|
|
VIGL
9
DELISTED
Vigil Neuroscience
VIGL
| $998K | 0.81% | 560,595 | – | – |
|
10
IO Biotech
IOBT
$104M
| $942K | 0.76% | 864,197 | – | – |
|
11
Bolt Biotherapeutics
BOLT
$9.85M
| $757K | 0.61% | 1,891,467 | – | – |
|